✦ LIBER ✦

Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy

✍ Scribed by R.J. Feldman; W.G. Christen; A.R. Ahmed

Book ID: 108672044
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 324 KB
Volume: 166
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2011.10658.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The serum levels of sE-selectin are incr

The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corsticosteroid therapy

✍ L. D'AURIA; P.CORDIALI FEI; M. PIETRAVALLE; C. FERRARO; A. MASTROIANNI; C. BONIF 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Soluble E (sE)-selectin represents the soluble isoform of cellular E-selectin, an adhesion molecule synthesized only by endothelial cells. As a consequence, it may be considered a marker of endothelial activity. The aim of this study was therefore to evaluate the serum levels of sE-selectin in nine

Combination therapy with fludarabine and

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma : A phase 2 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Elizabeth R. Vazquez; David R. Spigel; Eric Raefsky; James D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first‐line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ## METHO